News | News By Subject | News by Disease News By Date | Search News

Investor News

Get Our FREE
Industry eNewsletter
Top Breaking News
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China     1/23/2015
New Contestant Named in Best Hair in Biopharma As Race for Crown Heats Up     1/22/2015
Biotech IPOs Up 22% Since "Bubble" Year of 2000, Shows New Data     1/19/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data     1/16/2015
J.P. Morgan: Juno Therapeutics (JUNO) Touts 10 New Drugs for Six Diseases, Loves New CAR-T Platform     1/16/2015
J.P. Morgan: AstraZeneca PLC (AZN) CEO Says He's Not Worried About Pricing Pressure     1/15/2015
J.P. Morgan: Valeant (VRX) Investors Should Expect "Small and Medium Sized" Deals in 2015, Says CFO     1/13/2015
Merck & Co. (MRK) Issues Updates on Strategic Initiatives, Opportunities     1/13/2015
J.P. Morgan: Express Scripts Inc. CEO Said it Will Take On Cancer Drug Pricing Next     1/13/2015
J.P. Morgan Breaking News: Medtronic, Inc. (MDT) to Return 50% of Cash Flow to Shareholders, Will Close Covidien (COV) Deal in Weeks     1/13/2015
BioSpace (DHX) Poll Finds Massive Support for Pfizer (PFE), AbbVie (ABBV) Bid     1/9/2015
Mylan Inc. (MYL) ex-CEO, Glass Lewis Battle Over Proxy Adviser Power     1/9/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech     1/9/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain     1/7/2015
Biotech Hedge Fund Manager's Son Shot Him Over Allowance Cut     1/7/2015

Featured Stories
Biotechs To Follow In 2015 Off Fresh Insider Moves     1/7/2015
Batu Biologics Releases 2014 Shareholder Letter     1/2/2015
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off     12/2/2014
Investors Expect Record Year for Biotech Venture Capital     11/25/2014
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC     10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist     10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC     10/20/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing     10/15/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech     10/10/2014
Cross-Over Investing All The Rage, Say VCs On Panel     10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report     10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas     10/3/2014
What Happened At BioPharm America 2014?     9/24/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential     8/26/2014
StemCells (STEM) Posts Letter To Shareholders     1/26/2015
Claritas Genomics Caps Landmark Year With New Investment After Launching Novel Diagnostic Tests For Childhood Disorders And Advancing The Application Of Next-Gen Sequencing In Routine Clinical Care     1/26/2015
Cardio3 BioSciences Announces Agenda And Webcast For 2015 NYC Investor Day     1/26/2015
Cord Blood America, Inc. Announces Preliminary Proxy Filing And Details Why A "YES" Vote To Increase Authorized Shares Is Requested     1/23/2015
Mallinckrodt plc Announces Share Repurchase Program     1/23/2015
Alder Biopharmaceuticals Inc. Announces Exercise In Full Of Option To Purchase Additional Shares     1/23/2015
Auspex Pharmaceuticals (ASPX) Announces Pricing Of Follow On Offering     1/23/2015
Radius (RDUS) Announces Pricing Of Public Offering     1/23/2015
Otonomy, Inc. (OTIC) Announces Pricing Of Follow-On Public Offering     1/23/2015
Zafgen (ZFGN) Announces Pricing Of Public Offering Of Common Stock     1/23/2015
Vitae Pharmaceuticals, Inc. (VTAE) Announces Pricing Of Follow-On Public Offering Of Common Stock     1/23/2015
BioMarin (BMRN) Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares     1/23/2015
Verastem, Inc. (VSTM) Announces Pricing Of Public Offering Of Common Stock     1/23/2015
Puma Biotechnology (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares     1/23/2015
Merck & Co. (MRK), On Behalf Of Its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Inc. (CBST), Announces Tender Offer For Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 And 1.875% Convertible Senior Notes Due 2020     1/23/2015

More News
No News Posted on that date

Career Tips
Where Does Sanofi (SAN.PA) Find the Best Employees?     1/23/2015
Genentech (RHHBY) Reveals Their Greatest Source of Who They Hire     1/22/2015
6 Rules Every Biotech Job Seeker Should Know     1/22/2015
6 Things You Must Know When Working With Recruiters, HR, and Hiring Managers     1/22/2015
The Ultimate Secret of Acing Behavioral Interviews     1/22/2015
Quit AND Collect Unemployment     1/8/2015
7 Job Search Tips For 2015 From Top Career Experts     1/8/2015
50 Most Common Interview Questions     1/8/2015
How To Revamp Your Resume For The 10-Second Initial Review     1/8/2015
How To Get Noticed By Employers: Advice From Cliniqa And DexCom (DXCM)     12/18/2014
Best Cover Letter Tips For 2015     12/18/2014
Top 10 Resume Tips For 2015     12/18/2014
5 Crucial Cover Letter Mistakes     12/18/2014
What AstraZeneca PLC (AZN) Is Looking For In Hiring Scientists And Execs     12/5/2014
3 Cover Letter Mistakes You May Not Realize You've Made     12/4/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news